Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,847 | 332 | 91.8% |
| Education | $610.28 | 31 | 8.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,655 | 70 | $0 (2024) |
| Amgen Inc. | $954.95 | 39 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $705.10 | 41 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $669.73 | 38 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $389.84 | 20 | $0 (2024) |
| Relypsa, Inc. | $344.75 | 17 | $0 (2019) |
| AKEBIA THERAPEUTICS INC | $336.99 | 18 | $0 (2024) |
| Novo Nordisk Inc | $267.42 | 8 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $202.45 | 11 | $0 (2023) |
| Fresenius USA Marketing, Inc. | $196.07 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,418 | 71 | Novo Nordisk Inc ($202.53) |
| 2023 | $1,207 | 65 | Otsuka America Pharmaceutical, Inc. ($200.58) |
| 2022 | $1,107 | 53 | Otsuka America Pharmaceutical, Inc. ($196.19) |
| 2021 | $629.70 | 32 | Amgen Inc. ($158.40) |
| 2020 | $679.64 | 26 | Otsuka America Pharmaceutical, Inc. ($371.21) |
| 2019 | $749.81 | 35 | Otsuka America Pharmaceutical, Inc. ($273.30) |
| 2018 | $723.40 | 34 | Otsuka America Pharmaceutical, Inc. ($207.43) |
| 2017 | $942.79 | 47 | Amgen Inc. ($231.03) |
All Payment Transactions
363 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Cardiology | ||||||
| 12/10/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $15.00 | General |
| Category: NEPHROLOGY | ||||||
| 12/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $10.43 | General |
| Category: Cardio-renal | ||||||
| 12/05/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: NEPHROLOGY | ||||||
| 12/04/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Phosphate binder for ESRD | ||||||
| 12/04/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Cardio-renal | ||||||
| 11/11/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Phosphate binder for ESRD | ||||||
| 11/09/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/06/2024 | CorMedix Inc. | DefenCath (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Catheter Lock Solution | ||||||
| 10/23/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 10/22/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2024 | Amgen Inc. | Aranesp (Biological), Parsabiv, TAVNEOS | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Nephrology | ||||||
| 10/06/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: NEPHROLOGY | ||||||
| 10/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.69 | General |
| 09/25/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: Immunology | ||||||
| 09/09/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Hyperkalemia | ||||||
| 09/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: Cardio-renal | ||||||
| 08/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/13/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Diabetes | ||||||
| 08/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: Cardio-renal | ||||||
| 08/07/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Nephrology | ||||||
| 08/01/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Hyperkalemia | ||||||
| 07/31/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: NEPHROLOGY | ||||||
| 07/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 400 | 777 | $162,095 | $90,657 |
| 2022 | 13 | 534 | 1,353 | $234,435 | $145,171 |
| 2021 | 15 | 811 | 2,525 | $387,582 | $234,334 |
| 2020 | 15 | 817 | 2,721 | $461,774 | $250,614 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 38 | 198 | $89,100 | $51,228 | 57.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 112 | 231 | $20,790 | $13,789 | 66.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 103 | $15,450 | $5,671 | 36.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 40 | 95 | $10,450 | $5,117 | 49.0% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 18 | 23 | $8,625 | $4,720 | 54.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 35 | 35 | $5,775 | $3,420 | 59.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $2,590 | $1,674 | 64.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 36 | $3,600 | $1,568 | 43.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 17 | $2,125 | $1,537 | 72.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $2,750 | $1,445 | 52.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 13 | 14 | $840.00 | $487.39 | 58.0% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 47 | 253 | $113,850 | $71,890 | 63.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 144 | 413 | $37,170 | $23,114 | 62.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 81 | 129 | $19,350 | $11,726 | 60.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 24 | 49 | $18,375 | $11,562 | 62.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 45 | 141 | $15,510 | $7,902 | 50.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 64 | 66 | $10,890 | $7,071 | 64.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 27 | 32 | $4,000 | $2,630 | 65.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 35 | $3,500 | $2,395 | 68.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $3,500 | $2,065 | 59.0% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 19 | 20 | $2,300 | $1,610 | 70.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $2,405 | $1,536 | 63.9% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2022 | 14 | 171 | $2,565 | $1,145 | 44.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 14 | 17 | $1,020 | $525.94 | 51.6% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 60 | 330 | $148,500 | $94,231 | 63.5% |
About Dr. Lozina Daneva, MD
Dr. Lozina Daneva, MD is a Nephrology healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144280405.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lozina Daneva, MD has received a total of $7,457 in payments from pharmaceutical and medical device companies, with $1,418 received in 2024. These payments were reported across 363 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($6,847).
As a Medicare-enrolled provider, Daneva has provided services to 2,562 Medicare beneficiaries, totaling 7,376 services with total Medicare billing of $720,776. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Richmond, VA
- Active Since 03/23/2006
- Last Updated 01/30/2008
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1144280405
Products in Payments
- JYNARQUE (Drug) $1,340
- Veltassa (Drug) $509.09
- RAYALDEE (Drug) $424.37
- FARXIGA (Drug) $398.87
- Kerendia (Drug) $389.84
- Parsabiv (Biological) $356.18
- Parsabiv (Drug) $351.16
- Auryxia (Drug) $345.36
- SAMSCA (Drug) $314.10
- LOKELMA (Drug) $306.23
- ACTHAR (Biological) $274.96
- Rayaldee (Drug) $221.16
- Velphoro (Drug) $179.52
- IBSRELA (Drug) $169.03
- AURYXIA (Drug) $158.09
- Sensipar (Drug) $150.35
- TARPEYO (Drug) $120.57
- LUPKYNIS (Drug) $119.15
- Ozempic (Drug) $100.08
- INJECTAFER (Drug) $90.42
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Richmond
Dr. Martin Starkman, M.d, M.D
Nephrology — Payments: $28,150
Todd Gehr, M.d, M.D
Nephrology — Payments: $15,356
Nilang Patel, M.d, M.D
Nephrology — Payments: $12,491
Rizwan Akhtar, M.d, M.D
Nephrology — Payments: $5,858
Sandy Gibson, Md, MD
Nephrology — Payments: $5,635
Jason Kidd, Md, MD
Nephrology — Payments: $5,421